Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?

KJ van Erpecum, MJ Sonneveld - European Journal of Internal …, 2021 - ejinme.com
… most deadly consequences of chronic hepatitis B. Globally, … treatment weighting (IPTW) and
propensity score–matched … carcinoma BCLC (Barcelona Clinic Liver Cancer) stage 0 or A (ie …

Clinical efficacy of treated chronic hepatitis B patients with low-level viremia

Y Gao, B Xuan, Y Yang, Y Cui, W Huang, C Bi - 2023 - researchsquare.com
… After propensity score (PSM), 30 patients in the changed … , liver cancer and drug resistance
in patients with hepatitis B (4-6)… , and the side effects of the analogues themselves were small. …

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores

Y Huang, L Chen, R Huang, C Zhu… - Therapeutic …, 2022 - journals.sagepub.com
Propensity score matching (PSM) was used to control … Several HCC risk scores for patients
with chronic hepatitis B … See the impact this article is making through the number of times …

Risk of hepatocellular carcinoma with tenofovir vs entecavir treatment for chronic hepatitis B virus: a reconstructed individual patient data meta-analysis

DJH Tan, CH Ng, PWL Tay, N Syn… - JAMA network …, 2022 - jamanetwork.com
Nucleos(t)ide analogues reduce the risk of HCC in patients … from high-quality, propensity
score–matched cohort studies to … the beneficial effect of tenofovir on hepatocarcinogenesis. On …

Association of prophylactic anti–hepatitis B virus therapy with improved long-term survival in patients with hepatocellular carcinoma undergoing transarterial therapy

JW Jang, SH Yoo, HC Nam, BH Jang… - Clinical Infectious …, 2020 - academic.oup.com
… confounders on the estimated treatment effect. We calculated propensity score (PS) using …
for all subgroups stratified by Barcelona Clinic Liver Cancer (BCLC) stages and HBV viremia …

Entecavir versus tenofovir on prognosis of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy

WY Kao, ECH Tan, HL Lee, YH Huang… - Alimentary …, 2023 - Wiley Online Library
… HCC (Barcelona Clinic Liver Cancer [BCLC] stage 0, A or B) who … Thus, we employed the
propensity score obtained using the … effect of concomitant treatment of antivirus therapy, we …

Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B: a systematic review and meta-analysis

H Liu, Y Shi, JC Hayden, PM Ryan, J Rahmani, G Yu - Liver Cancer, 2020 - karger.com
… in virologic response, but their effect on the development of … We also used propensity
score matching to minimize … entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A …

[HTML][HTML] Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: Individual patient data meta-analysis

…, WR Kim, LJ Yee, C Brooks-Rooney, T Curteis… - Journal of …, 2023 - Elsevier
Treatment effect consistency was explored in propensity … , effective treatment with nucleo(s)tide
analogue (NA) therapies is critical … analysis (primary analysis approach), propensity score

Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy

T Keitoku, N Tamaki, M Kurosaki, K Inada… - … of Viral Hepatitis, 2023 - Wiley Online Library
… In conclusion, in patients with chronic hepatitis B who received NA therapy, advanced fibrosis
… on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis. J …

Hepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicentre cohort study

M Papatheodoridi, TH Su, E Hadziyannis… - Liver …, 2022 - Wiley Online Library
… Scarce data exist on the effect of nucleos(t)ide analogue (NA) … of treatment discontinuation
on HCC risk, we performed a 1:1 propensity score (PS) matching analysis adjusting for patient